Whales with a lot of money to spend have taken a noticeably bullish stance on SpringWorks Therapeutics.
Looking at options history for SpringWorks Therapeutics SWTX we detected 68 trades.
If we consider the specifics of each trade, it is accurate to state that 42% of the investors opened trades with bullish expectations and 32% with bearish.
From the overall spotted trades, 3 are puts, for a total amount of $125,618 and 65, calls, for a total amount of $3,475,358.
Projected Price Targets
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $25.0 to $60.0 for SpringWorks Therapeutics over the recent three months.
Volume & Open Interest Trends
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for SpringWorks Therapeutics's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across SpringWorks Therapeutics's significant trades, within a strike price range of $25.0 to $60.0, over the past month.
SpringWorks Therapeutics 30-Day Option Volume & Interest Snapshot
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SWTX | CALL | TRADE | NEUTRAL | 02/21/25 | $12.8 | $11.2 | $12.0 | $45.00 | $270.0K | 4.8K | 2.0K |
| SWTX | CALL | TRADE | BULLISH | 02/21/25 | $21.0 | $20.0 | $21.0 | $30.00 | $203.7K | 308 | 144 |
| SWTX | CALL | SWEEP | BULLISH | 02/21/25 | $13.4 | $12.5 | $13.4 | $40.00 | $116.5K | 3.9K | 732 |
| SWTX | CALL | TRADE | BULLISH | 02/21/25 | $27.1 | $24.3 | $26.0 | $30.00 | $104.0K | 308 | 204 |
| SWTX | CALL | TRADE | NEUTRAL | 02/21/25 | $16.5 | $14.7 | $15.5 | $40.00 | $97.6K | 3.9K | 910 |
About SpringWorks Therapeutics
SpringWorks Therapeutics Inc is a clinical stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.
Where Is SpringWorks Therapeutics Standing Right Now?
- Currently trading with a volume of 10,783,844, the SWTX's price is up by 37.09%, now at $55.22.
- RSI readings suggest the stock is currently may be overbought.
- Anticipated earnings release is in 10 days.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for SpringWorks Therapeutics with Benzinga Pro for real-time alerts.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
